IRIS
DANIELI, Maria Giovanna
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 8.197
EU - Europa 3.460
AS - Asia 2.976
SA - Sud America 718
Continente sconosciuto - Info sul continente non disponibili 254
AF - Africa 145
OC - Oceania 8
Totale 15.758
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 7.862
SG - Singapore 951
IT - Italia 877
VN - Vietnam 697
BR - Brasile 553
RU - Federazione Russa 526
CN - Cina 481
UA - Ucraina 388
DE - Germania 301
IE - Irlanda 242
SE - Svezia 226
HK - Hong Kong 221
FR - Francia 206
CA - Canada 181
GB - Regno Unito 176
FI - Finlandia 170
DK - Danimarca 138
BD - Bangladesh 110
TR - Turchia 110
IN - India 88
KR - Corea 75
MX - Messico 66
NL - Olanda 66
AR - Argentina 53
MA - Marocco 46
CI - Costa d'Avorio 41
IQ - Iraq 38
PL - Polonia 29
PK - Pakistan 27
PH - Filippine 25
EC - Ecuador 24
ZA - Sudafrica 24
ID - Indonesia 23
CO - Colombia 21
JP - Giappone 21
LT - Lituania 21
ES - Italia 20
VE - Venezuela 20
AT - Austria 19
BE - Belgio 17
CL - Cile 17
NI - Nicaragua 14
UZ - Uzbekistan 14
HN - Honduras 13
IL - Israele 13
GT - Guatemala 11
SA - Arabia Saudita 11
TN - Tunisia 11
CR - Costa Rica 10
CW - ???statistics.table.value.countryCode.CW??? 10
PY - Paraguay 10
PE - Perù 8
TT - Trinidad e Tobago 8
TW - Taiwan 8
AU - Australia 7
JM - Giamaica 7
JO - Giordania 7
PR - Porto Rico 7
SV - El Salvador 7
TH - Thailandia 7
IR - Iran 6
RS - Serbia 6
AE - Emirati Arabi Uniti 5
AL - Albania 5
CH - Svizzera 5
KZ - Kazakistan 5
MY - Malesia 5
UY - Uruguay 5
AZ - Azerbaigian 4
DZ - Algeria 4
NP - Nepal 4
RO - Romania 4
BO - Bolivia 3
DO - Repubblica Dominicana 3
ET - Etiopia 3
EU - Europa 3
GP - Guadalupe 3
GR - Grecia 3
MD - Moldavia 3
OM - Oman 3
PS - Palestinian Territory 3
UG - Uganda 3
BH - Bahrain 2
CZ - Repubblica Ceca 2
EG - Egitto 2
GY - Guiana 2
HU - Ungheria 2
KE - Kenya 2
KW - Kuwait 2
LB - Libano 2
NG - Nigeria 2
QA - Qatar 2
SC - Seychelles 2
SR - Suriname 2
BA - Bosnia-Erzegovina 1
BB - Barbados 1
BG - Bulgaria 1
BY - Bielorussia 1
BZ - Belize 1
DM - Dominica 1
Totale 15.498
Salva come PNG Salva come JPEG
Città #
Ashburn 1.467
Dallas 1.041
Singapore 581
Jacksonville 393
San Jose 391
Chandler 388
Council Bluffs 327
Fairfield 257
Dublin 233
Boardman 229
Ho Chi Minh City 223
Hong Kong 212
New York 193
Hanoi 167
Wilmington 152
Woodbridge 144
Los Angeles 138
The Dalles 133
Beijing 127
Lauterbourg 109
Moscow 109
Seattle 107
Munich 102
Houston 101
Ann Arbor 97
Princeton 97
Helsinki 92
Lawrence 87
Des Moines 85
Milan 84
San Mateo 82
Cambridge 66
Montréal 62
Santa Clara 60
Centro 59
São Paulo 55
Hefei 53
Montreal 51
Phoenix 51
Mcallen 49
Ancona 45
Orem 44
San Diego 42
Abidjan 41
Buffalo 39
Chicago 39
Da Nang 32
Rome 32
Mexico City 31
Turin 31
Warsaw 27
Atlanta 25
Washington 25
Chennai 24
Haiphong 22
Shanghai 20
Amsterdam 19
Florence 19
Brooklyn 18
Frankfurt am Main 18
London 18
Pune 17
Tokyo 17
Brussels 16
Guangzhou 16
Redmond 16
Baghdad 15
Naples 15
Palermo 15
Stockholm 15
Toronto 15
Hải Dương 14
Johannesburg 14
Managua 14
Rio de Janeiro 14
Tashkent 14
Wuhan 14
Castelfidardo 13
Denver 13
Manchester 13
Miano 13
Nuremberg 13
Vilnius 13
Boston 12
Brasília 12
Poplar 12
Saint Petersburg 12
San Francisco 12
Thái Bình 12
Dhaka 11
Salvador 11
Ankara 10
Bologna 10
Columbus 10
Curitiba 10
Guatemala City 10
Lahore 10
Norwalk 10
Salt Lake City 10
Turku 10
Totale 9.568
Salva come PNG Salva come JPEG
Nome #
Prurigo nodularis as the first manifestation of a common variable immunodeficiency 353
Insights from comparison of serum IgG4 between T2-eosinophilic asthma and eosinophilic granulomatosis with polyangiitis/idiopathic hypereosinophilic syndrome 267
Expanding the mosaic functions of intravenous immunoglobulin 245
Use of nailfold capillaroscopy for the early diagnosis of systemic sclerosis in patients with primary biliary cholangitis 228
7th International Immunoglobulin Conference: Immunomodulation. 215
Colonna vertebrale. Midollo spinale. Imaging 213
ANCA-negative EGPA: only eosinophils without vasculitis? Insights from anti-T2 biologics 195
Clinical features and follow-up in patients with 22q11.2 deletion syndrome. 194
La scelta della maternità. Una guida alla decisione per le donne con LES 193
CENTRAL NERVOUS SYSTEM INVOLVEMENT IN SYSTEMIC LUPUS ERYTHEMATOSUS PATIENTS WITHOUT OVERT NEUROPSYCHIATRIC MANIFESTATIONS 186
IMMUNOSUPPRESSIVE THERAPY IN LUPUS NEPHRITIS: A RANDOMISED TRIAL OF LOW DOSE VERSUS HIGH DOSE INTRAVENOUS CYCLOPHOSPHAMIDE. THE EUROLUPUS NEPHRITIS TRIAL. 180
Global longitudinal strain measured by speckle tracking identifies subclinical heart involvement in patients with systemic sclerosis 179
A Case of CVID-Associated Inflammatory Bowel Disease with CTLA-4 Mutation Treated with Abatacept 179
Overexpression of the cytokine BAFF and autoimmunity risk 168
Intravenous immunoglobulin as a therapy for autoimmune conditions 167
Cardiac involvement in polymyositis and dermatomyositis 165
Azathioprine versus mycophenolate mofetil for long-term immunosuppression in lupus nephritis: Results from the MAINTAIN Nephritis Trial 165
Five-year follow-up of 165 Italian patients with undifferentiated connective tissue diseases. 164
Incidence of malignancy in patients with common variable immunodeficiency according to therapeutic delay: an Italian retrospective, monocentric cohort study 161
Active hepatitis C virus infection in bone marrow and peripheral blood mononuclear cells from patients with mixed cryoglobulinaemia. 157
The ten-year follow-up data of the Euro-lupus Nephritis Trial comparing low-dose versus high-dose intravenous cyclophosphamide. 156
The Italian Registry for Primary Immunodeficiencies (Italian Primary Immunodeficiency Network; IPINet): Twenty Years of Experience (1999–2019) 156
6th International Immunoglobulin Symposium: poster presentations. 153
Juvenile rheumatoid arthritis patients manifest immune reactivity to the mycobacterial 65-kDa heat shock protein, to its 180-188 peptide, and to a partially homologous peptide of the proteoglycan link protein. 152
Subcutaneous IgG in the Myositis Spectrum Disorders 152
Long term effectiveness of intravenous immunoglobulin in Churg-Strauss syndrome. 151
A proteinuria cut-off level of 0.7 g /day after 12 months of treatment best predicts long-term renal outcome in lupus nephritis: Data from the MAINTAIN Nephritis Trial 151
Antibodies to mycobacterial 65 kDa heat shock protein in systemic sclerosis (scleroderma). 149
Serum levels of soluble interleukin-2 receptor in patients with systemic lupus erythematosus and systemic idiopathic vasculitis. 148
Autoimmune thyroid diseases in patients with undifferentiated connective tissue disease. 147
Subcutaneous immunoglobulin in inflammatory myopathies: efficacy in different organ systems 147
Alarmins in autoimmune diseases 145
Association tests with systemic lupus erythematosus (SLE) of IL10 arkers indicate a direct involvement of a CA repeat in the 5' regulatory region 145
Undifferentiated connective tissue disease: natural history and evolution into definite CTD assessed in 84 patients initially diagnosed as early UCTD. 145
Subclinical Cardiac Dysfunction in Polymyositis and Dermatomyositis: A Speckle-tracking Case-control Study 143
Immunohistochemical localization of intracellular and extracellular associated TGF beta in the skin of patients with systemic sclerosis (scleroderma) and primary Raynaud's phenomenon. 142
Shift from intravenous or 16% subcutaneous replacement therapy to 20% subcutaneous immunoglobulin in patients with primary antibody deficiencies 141
The EuroMyositis registry: An international collaborative tool to facilitate myositis research 140
la terapia con immunoglobuline endovena nel trattamento delle malattie autoimmuni 140
A machine learning analysis to predict the response to intravenous and subcutaneous immunoglobulin in inflammatory myopathies. A proposal for a future multi-omics approach in autoimmune diseases 139
[Therapy of refractory rheumatoid arthritis. Cyclosporin and methotrexate combination] 136
Subcutaneous immunoglobulin in polymyositis and dermatomyositis: a novel application. 135
Prolactin and prolactin receptor gene polymorphisms in multiple sclerosis and systemic lupus erythematosus. 135
Bullous SLE: response to methotrexate and relationship with disease activity 134
Dr. Guerra, et al reply 134
Facilitated Subcutaneous Immunoglobulin (fSCIg) in Autoimmune Cytopenias Associated with Common Variable Immunodeficiency 134
Cyclosporin A and intravenous immunoglobulin treatment in polymyositis/dermatomyositis. 132
Autoimmunità, Gravidanza, Contraccezione, Terapia ormonale 131
Efficacy and safety of intravenous and subcutaneous immunoglobulin therapy in idiopathic inflammatory myopathy: A systematic review and meta-analysis 130
Two single-nucleotide polymorphisms in the 5' and 3' ends of the osteopontin gene contribute to susceptibility to systemic lupus erythematosus. 129
Replacement and Immunomodulatory Activities of 20% Subcutaneous Immunoglobulin Treatment: A Single-Center Retrospective Study in Autoimmune Myositis and CVID Patients 126
Self-administered hyaluronidase-facilitated subcutaneous immunoglobulin therapy in complicated primary antibody deficiencies 124
Early response to immunosuppressive therapy predicts good renal outcome in lupus nephritis: lessons from long-term followup of patients in the Euro-Lupus Nephritis Trial. 122
Familial autoimmunity as a risk factor for systemic lupus erythematosus and vice versa: a case-control study. 122
Potential Anti-Tumor Activity of Intravenous and Subcutaneous Immunoglobulin 122
Common Variable Immunodeficiency in Elderly Patients: A Long-Term Clinical Experience 122
A machine learning analysis to evaluate the outcome measures in inflammatory myopathies 121
Clinical Characteristics of Anti-Synthetase Syndrome: Analysis From the Classification Criteria for Anti-Synthetase Syndrome Project 120
Autoimmunità Gravidanza Contraccezione Terapia Ormonale 120
Exposome: Epigenetics and autoimmune diseases 119
Clinical and serological associations of ribosomal P autoantibodies in systemic lupus erythematosus: prospective evaluation in a large cohort of Italian patients. 119
Intravenous Immunoglobulin and Mycophenolate Mofetil for Long-Standing Sensory Neuronopathy in Sjögren's Syndrome 117
Impact of treatment on survival in polymyositis and dermatomyositis. A single-centre long-term follow-up study. 116
Rare variants in the TREX1 gene and susceptibility to autoimmune diseases. 115
Repeat kidney biopsies fail to detect differences between azathioprine and mycophenolate mofetil maintenance therapy for lupus nephritis: data from the MAINTAIN Nephritis Trial 115
Systemic lupus in Europe at the change of the millennium: lessons from the "Euro-lupus Project" 115
Management of a pregnant woman with common variable immunodeficiency and previous reactions to intravenous IgG administration 114
Clinical Associations of Biallelic and Monoallelic TNFRSF13B Variants in Italian Primary Antibody Deficiency Syndromes 114
Efficacy and safety of intravenous and subcutaneous tocilizumab in a cohort of patients affected by rheumatoid arthritis in real-life 114
Open-label study on treatment with 20 % subcutaneous IgG administration in polymyositis and dermatomyositis. 113
Quantitative assessment of salivary gland inflammatory infiltration in primary Sjögren's syndrome: its relationship to different demographic, clinical and serological features of the disorder. 112
La terapia immunosoppressiva nelle miositi refratttarie 111
Ultrasonographic contrast-enhanced study of sicca syndrome 111
Platelet-activating factor acetylhydrolase: A biomarker in Hymenoptera venom allergy? 109
Low-dose intravenous immunoglobulin (IVIg) in different immune-mediated conditions 107
Oxidative stress, mitochondrial dysfunction, and respiratory chain enzyme defects in inflammatory myopathies 106
Risk factors for Sjögren's syndrome: a case-control study. 106
Subcutaneous IgG in immune-mediate diseases: proposed mechanisms of action and literature review. 106
Polyautoimmunity Reflecting Immune Dysregulation in Common Variable Immunodeficiency 105
Machine learning application in autoimmune diseases: State of art and future prospectives 105
Sinchronised therapy and high-dose cyclophosphamide in proliferative lupus nephritis. 105
Functional variants in the B-cell gene BANK1 are associated with systemic lupus erythematosus. 104
Hydroxychloroquine-induced seizure in a patient with systemic lupus erythematosus. 103
High-dose Facilitated subcutaneous Immunoglobulin in a Patient with refractory Polymyositis and severe Interstitial Lung disease 103
Hypogammaglobulinemia in patients affected by limited cutaneous systemic sclerosis: Case series and review of the literature 102
Type 1 diabetes, COVID-19 vaccines and short-term safety: Subgroup analysis from the global COVAD study 102
Differential risk of non-Hodgkin's lymphoma in Italian patients with primary Sjögren's syndrome. 101
Subcutaneous immunoglobulins in ocular myositis. 101
Autoimmunity, COVID-19, Post-COVID19 Syndrome and COVID-19 Vaccination 100
Initial presenting manifestations in 16,486 patients with inborn errors of immunity include infections and noninfectious manifestations 100
The Impact of SARS-CoV-2 Infection in Patients with Inborn Errors of Immunity: the Experience of the Italian Primary Immunodeficiencies Network (IPINet) 99
Intravenous immunoglobulin as add on treatment with mycophenolate mofetil in severe myositis. 98
The European Society for Immunodeficiencies (ESID) registry 2014 98
Long-term follow-up of the MAINTAIN Nephritis Trial, comparing azathioprine and mycophenolate mofetil as maintenance therapy of lupus nephritis 98
Identification of a new putative functional IL18 gene variant through an association study in systemic lupus erythematosus 98
Intravenous immunoglobulin as an important adjunct in the prevention and therapy of coronavirus 2019 disease 98
Systemic sclerosis and COVID-19 vaccine safety: short-term insights from the global COVID-19 vaccination in autoimmune disease (COVAD) survey 97
Lessons from the "Euro-Lupus Cohort". 94
Subcutaneous immunoglobulin G in idiopathic inflammatory myopathies: therapeutic implications. 93
Response to: 'Antisynthetase syndrome or what else? Different perspectives indicate the need for new classification criteria' by Cavagnaet al 92
Totale 13.680
Salva come PNG Salva come JPEG
Categoria #
all - tutte 68.431
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 68.431
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022420 0 0 0 0 3 35 45 58 46 44 74 115
2022/20231.263 104 115 99 104 104 169 5 82 324 13 99 45
2023/2024915 158 40 56 123 143 188 18 34 10 32 19 94
2024/20251.759 134 170 75 31 66 94 178 91 326 158 180 256
2025/20266.977 306 878 629 654 695 448 1.140 641 536 606 191 253
2026/20271.564 309 230 256 713 56 0 0 0 0 0 0 0
Totale 15.758